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Psychotic Experiences and Neuropsychological Functioning
in a Population-based Sample
JosephineMollon, MSc; Anthony S. David, MD, FRCPsych; Craig Morgan, MSc, PhD; Souci Frissa, PhD; David Glahn, PhD;
Izabela Pilecka, BSc; Stephani L. Hatch, PhD; Matthew Hotopf, MRCPsych, PhD; Abraham Reichenberg, PhD
IMPORTANCE Psychotic experiences in early life are associated with neuropsychological
impairment and the risk for later psychiatric disorders. Psychotic experiences are also
prevalent in adults, but neuropsychological investigations spanning adulthood are limited,
and confounding factors have not been examined rigorously.
OBJECTIVE To characterize neuropsychological functioning in adults with psychotic
experiences while adjusting for important sociodemographic characteristics and familial
factors and investigating the effect of age.
DESIGN, SETTING, AND PARTICIPANTS The South East London Community Health (SELCoH)
study is a population-based household survey of physical andmental health in individuals 16
years or older conducted from June 1, 2008, to December 31, 2010, in 2 London boroughs.
The study included 1698 participants from 1075 households. Data were analyzed fromMay 6,
2014, to April 22, 2015.
EXPOSURES Psychotic experiences measured using the Psychosis Screening Questionnaire.
MAIN OUTCOMES ANDMEASURES Neuropsychological functioningmeasured using tests
assessing verbal knowledge (Wechsler Test of Adult Reading), working memory (Spatial
Delayed Response Task), memory (Visual Object Learning Task), and processing speed (digit
symbol coding task). A composite IQ score of general cognitive ability was calculated.
RESULTS A total of 1677 participants with amean (SD) age of 40 (17) years were included in
the analysis. Comparedwith the groupwithout psychotic experiences, the 171 (9.7%) adults
with psychotic experiences did not show a statistically significant impairment onmean (SD)
measures of IQ (95.25 [16.58] vs 100.45 [14.77]; Cohen d, −0.22; P = .06) or processing speed
(40.63 [13.06] vs 42.17 [13.79]; Cohen d, −0.03; P = .73) but were impaired onmeasures of
verbal knowledge (31.36 [15.78] vs 38.83 [12.64]; Cohen d, −0.37; P = .003), workingmemory
(20.97 [4.12] vs 22.51 [3.26]; Cohen d, −0.34; P = .005), andmemory (43.80 [8.45] vs 46.53
[7.06]; Cohen d, −0.28; P = .01). Only participants 50 years and older with psychotic
experiences showedmedium to large impairments in neuropsychological functioning (mean
[SD]) onmeasures of IQ (81.22 [15.97] vs 91.28 [14.31]; Cohen d, −0.70), verbal knowledge
(28.31 [13.83] vs 38.51 [11.50]; Cohen d, −0.88), workingmemory (19.11 [4.77] vs 21.99 [3.42];
Cohen d, −0.82), andmemory (39.17 [8.23] vs 44.09 [6.51]; Cohen d, −0.45) after adjusting for
socioeconomic status, cannabis use, and commonmental disorders. Medium impairments
(mean [SD]) onmeasures of workingmemory (21.27 [3.64] vs 22.62 [2.97]; Cohen d, −0.45)
andmemory (44.32 [5.84] vs 46.91 [5.74]; Cohen d, −0.45) were seen in those aged 35 to 49
years and on ameasure of verbal knowledge (30.81 [14.17] vs 37.60 [10.48]; Cohen d, −0.62) in
those aged 16 to 24 years. First-degree relatives of adults with psychotic experiences showed a
small impairment on ameasure of verbal knowledge (34.71 [12.10] vs 38.63 [10.97]; Cohen d,
−0.36; P = .02), and unrelated cohabitants showed no neuropsychological impairment.
CONCLUSIONS AND RELEVANCE The profile of cognitive impairment in adults with psychotic
experiences differed from that seen in adults with psychotic disorders, suggesting important
differences between subclinical and clinical psychosis.
JAMA Psychiatry. doi:10.1001/jamapsychiatry.2015.2551
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S chizophrenia has a lifetime prevalence of approxi-mately 1%andcombinedpsychoticdisordersof approxi-mately3%.1,2Asubstantialminorityof thegeneralpopu-
lation also reports subclinical psychotic experiences,with the
World Health OrganizationWorldMental Health Surveys3 re-
porting a lifetime prevalence of 5.8%worldwide and of 6.8%,
7.2%, and 3.2% in high-, middle-, and low-income countries,
respectively. Evidence suggests that subclinical psychotic ex-
periences may lie on a continuum with clinically significant
psychotic symptoms and therefore be informative for re-
search into the cause of psychotic illness. First, psychotic ex-
periences and psychotic disorders share risk factors, includ-
ing lowIQ,childhoodmaltreatment,andstressful lifeevents.4,5
Second, imaging studies report pathophysiologic overlaps be-
tween subclinical and clinical psychosis, includinghypofron-
tality, frontotemporal disconnection, and deficits in gray and
whitematter.6-8 Finally, psychotic experiences in early life are
associatedwith an increased risk for later psychotic illness9,10
and in adulthood with later hospitalization for a psychotic
disorder.11 However, psychotic experiences are also associ-
atedwithnonpsychotic psychiatric disorders, including anxi-
ety, depression,12,13 and suicidal thoughts and behavior.14,15
Lending support to this hypothesized psychosis con-
tinuum are the small neuropsychological impairments seen in
people with psychotic experiences. (Table 1 and eMethods
and eFigure 1 in the Supplement report results of a meta-
analysis of previous population studies of neuropsychological
functioning and psychotic experiences).4,5,16-40 Neuropsycho-
logical impairment is a core feature of schizophrenia41,42; it
emerges early and remains relatively stable throughout the
course of the illness.43 The most severe impairment is re-
ported in processing speed,44,45 but deficits in episodic
memory and working memory have been proposed as core
features.46 A similar profile of impairment has been reported
in people with psychotic experiences,19,20 but most of the
studies have focused on child and adolescent samples,
despite evidence that psychotic experiences are prevalent
across the life course.3,5,47,48 Only 1 study in ourmeta-analysis
investigated the neuropsychological correlates of psychotic
experiences across adulthood5 and reported on a single cogni-
tive domain. Moreover, previous studies have not adjusted for
key sociodemographic confounders, whose importance is
highlighted by the World Mental Health Surveys’ finding of
higher prevalences of psychotic experiences in middle- and
high-income countries compared with low-income
countries.3 Finally, the association between psychotic experi-
ences and neuropsychological functioning may be con-
founded by shared familial factors.49
In thepresent studyweexaminedsubclinicalpsychoticex-
periences andneuropsychological functioning in adults from
an ethnically and sociodemographically diverse population.
Our study was unique in examining the effects of (1) impor-
tant confounders, includingcannabisuseandpsychiatricmor-
bidity, (2) age, and (3) confounding by familial factors on the
associationbetweenpsychotic experiences andneuropsycho-
logical functioning. We hypothesized that psychotic experi-
ences would be associated with a profile of cognitive impair-
mentsimilar,yetmilder, to thatof schizophrenia, characterized
by specific deficits in processing speed and memory seen in
the context of a generalized deficit.
Methods
Sample
TheSouthEast LondonCommunityHealth (SELCoH) study is
apopulation-basedhouseholdsurveycompleted in2010 in the
Londonboroughs of Lambeth andSouthwark. The aimwas to
provide prevalence estimates of mental and physical health
symptoms inanethnicallyandsocioeconomicallydiverse,geo-
graphically defined, inner-city community. A randomsample
ofhouseholdswas identifiedusing theSmallUserPostcodeAd-
dressFile (http://www.poweredbypaf.com/),whichhasnearly
complete coverage of private households in the United King-
dom. Introductory lettersweresent tohouseholds,whichwere
visitedup to4 timesatdifferent timesof thedayand theweek.
Whencontactwasmade,written informedconsentwassought
fromasmany eligible (aged ≥16 years)members of the house-
hold as possible; all study participants provided written in-
formed consent. Contact was established with 2070 private
households, of which 1075 had at least 1 member inter-
viewed, representing a 51.9%householdparticipation rate.Of
2359 individuals eligible within the participating house-
holds, 1698 (72.0%) participated (a detailed description can
be found inHatch et al50). This studywas approved by the re-
search ethics committee of King’s College London.
Procedure
Datawerecollectedusingacomputer-assisted interviewsched-
ule,whichwaspiloted to establish reliability, validity, and fea-
sibility. Data were collected from June 1, 2008, to December
31, 2010. Participants received £15 for participation.
Measures
Psychotic Experiences
The Psychosis Screening Questionnaire (PSQ)51 was used to
measure psychotic experiences. The PSQ is an interviewer-
administered questionnaire that assesses psychotic experi-
ences in theprecedingyear and consists of 5 sections covering
hypomania, thought disorder, paranoia, strange experiences,
and hallucinations. Items on hypomania were discarded be-
cause the focus was on psychosis. Each section has an initial
probe, followedby secondaryquestion(s),which establish the
quality of psychotic experiences. The PSQ has been validated
in2national surveys in theUnitedKingdom.52,53 In this study,
those participants who endorsed 1 or more secondary ques-
tionsat thehighest level on thePSQwere comparedwith those
who did not5 (eTable 1 in the Supplement).
Neuropsychological Functioning
Verbal knowledge was assessed using the Wechsler Test of
AdultReading (WTAR),54workingmemorywith theSpatialDe-
layed Response Task (SDRT),55 visual memory with the Vi-
sualObjectLearningTask (VOLT),56 andprocessing speedwith
a digit symbol coding task (DSCT)57,58 (eTable 2 in the Supple-
ment). Neuropsychological tests were administered using a
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computer as in previous schizophrenia and bipolar disorder
studies in which impairments of expected effect sizes were
shown.59-63We calculated a general cognitive ability compos-
ite score as the first principal component of a factor analysis
using all the neuropsychological tests administered.64 Scores
were transformed to an IQ-like scorewithmeanof 100andSD
of 15.
Confounders
The interviewestablishedethnicity, age, andoccupation clas-
sified according to the Registrar General65 as professional (I),
managerial/technical (II), skilled nonmanual (III-NM), skilled
manual (III-M), semiskilled (IV), unskilled (V), and unclassi-
fied. Common mental disorders were assessed using the Re-
visedClinical InterviewSchedule (CIS-R),66which asks about
Table 1. Studies Investigating Neuropsychological Functioning and Psychotic Experiences
Domain by Source
No. of
Participants
Age at Measurement
of Cognition, y
Age at Measurement
of Psychotic Experiences, y
Rate of Psychotic
Experiences, %
Effect Size,
Cohen d
IQa
Polanczyk et al,4 2010 2127 5 12 5.9 −0.51
Kremen et al,16 1998 547 4 and 7 23 3.2 −0.61
Horwood et al,17 2008 6384 8 12 13.8 −0.08
Cannon et al,18 2002 789 3-11 11 14.7 −0.52
Pooled effect size NA NA NA NA −0.40
General cognitionb
Niarchou et al,19 2013 6784 8, 10, and 11 12 11.6 −0.05
Kelleher et al,20 2012 165 11-13 11-13 25.5 −0.03
Barnett et al,21 2012 2916 8, 11, and 15 53 22.3 −0.16
Gur et al,22 2014 4275 8-21 8-21 15.5 −0.42
Johns et al,5 2004 8520 16-74 16-74 5.5 −0.34
Pooled effect size NA NA NA NA −0.19
Processing speedc
Niarchou et al,19 2013 6784 8, 10, and 11 12 11.6 −0.13
Kelleher et al,20 2012 165 11-13 11-13 25.5 −0.30
Gur et al,22 2014 4275 8-21 8-21 15.5 −0.29
Henderson et al,23 1998 870 78 78 7.5 −0.24
Ostling et al,24 2004 245 85 85 14.3 −0.56
Pooled effect size NA NA NA NA −0.20
Working memoryd
Niarchou et al,19 2013 6784 8, 10, and 11 12 11.6 −0.07
Kelleher et al,20 2012 165 11-13 11-13 25.5 −0.09
Gur et al,22 2014 4275 8-21 8-21 15.5 −0.29
Ostling et al,24 2004 245 85 85 14.3 −0.33
Pooled effect size NA NA NA NA −0.18
Memorye
Kelleher et al,20 2012 165 11-13 11-13 25.5 −0.18
Gur et al,22 2014 4275 8-21 8-21 15.5 −0.32
Ostling et al,24 2004 245 85 85 14.3 −0.29
Pooled effect size NA NA NA NA −0.31
Abbreviation: NA, not applicable.
a IQmeasures include Vocabulary and Block Design subtests of Wechsler
Preschool and Primary Scale of Intelligence–Revised29 for Polanczyk et al4;
Stanford-Binet Intelligence Scale (age 4 years)26 and Information, Vocabulary,
Digit Span, Comprehension, Block Design, Picture Arrangement, and Coding
subscales of Wechsler Intelligence Scale for Children (WISC) (age 7 years)30 for
Kremen et al16; WISC III28 for Horwood et al17; and Peabody Picture
Vocabulary Test (age 3 years),25 Stanford-Binet Intelligence Scale (age 5
years),26 andWISC (ages 7, 9, and 11 years)27 for Cannon et al.18
bGeneral cognitionmeasures include Picture Completion, Picture Arrangement,
Block Design, and Object Assembly subtests of WISC III28 for Niarchou et
al19;Wide Range Achievement Test 431 for Kelleher et al20; Picture Intelligence,
Reading, Sentence Completion, and Vocabulary (age 8 years), Arithmetic,
Reading, Vocabulary, Verbal, and Nonverbal IQ (age 11 years), andMaths,
Reading, Verbal, and Nonverbal IQ (age 15 years) from AH4 Group Test of
Intelligence33 for Barnett et al21; the Verbal Reasoning, Nonverbal Reasoning,
and Spatial Processing subtests of the Computerized Neurocognitive
Battery (CNB)32 for Gur et al22; and National Adult Reading Test34 for Johns
et al.5
c Processing speedmeasures include Sky Search Task from Tests for Everyday
Attention for Children36 and the Coding subtest of WISC III28 for Niarchou et
al19; Symbol Coding and Category Fluency in Trail Making Test fromMATRICS
neurocognitive battery35 for Kelleher et al20; Symbol Letter Modalities Test37
for Henderson et al23; and Identical Forms Test38 for Ostling et al.24
dWorkingmemorymeasures include Backward Digit Span and Arithmetic from
WISC III28 for Niarchou et al19; Spatial Span and Letter Number Span of
Wechsler Memory Scale fromMATRICS neurocognitive battery35 for Kelleher
et al20;Abstraction andMental Flexibility and Attention andWorking Memory
subtests of CNB32 for Gur et al22; and Digit Span for Ostling et al.24
e Memorymeasures includeHopkins Verbal Learning Test fromMATRICS
neurocognitive battery35 for Kelleher et al20;Words, Faces, and Shapes subtests
of CNB32 for Gur et al22; and Thurstone PictureMemory Test38 andMemory in
Reality, Prose Recall, and TenWordMemory Test40 for Ostling et al.24
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the following 14 symptomdomainsduring thepreviousweek:
fatigue, sleepproblems, irritability,worry, depression,depres-
sive ideas, anxiety, obsessions, subjective memory and con-
centration, somatic symptoms, compulsions, phobias, physi-
cal health worries, and panic. A score of 18 or more indicates
thepresenceofacommonmentaldisorder.Goodreliabilityand
validity of the Revised Clinical Interview Schedule have been
reported.66,67 Cannabis use in the past year was also re-
ported.Ethnicity,occupation,cannabisuse,andcommonmen-
tal disorders were correlated significantly with psychotic ex-
periences andneuropsychological functioning, butminimally
correlatedwith one another (eTable 3 in the Supplement). In-
teractions of group (participants with psychotic experiences
or control participants) by confounder (ethnicity, occupa-
tion, cannabis use, and commonmental disorders) with cen-
tered variables68 on all tests were not statistically significant
except for the group by ethnicity interaction on IQ (P = .03).
Familial Factors
We investigated familial factors bydividing the cohabitants of
participantswithpsychotic experiences into2groups.The first
group included first-degree relatives (eg, biological child, bio-
logical sibling); the second, nongenetically related cohabi-
tants (eg, spouse, nonbiological child).
Data Analysis
Datawere analyzed fromMay6, 2014, toApril 22, 2015.Analy-
ses were completed in STATA software (version 13; Stata-
Corp). Appropriate survey commands (svy)were used to gen-
erate robust SEs. All analyses of SELCoH data accounted for
clusteringbyhousehold inherent in the studydesignandwere
weighted for within-household nonresponse.50
We used linear regression (adjusting for ethnicity, occu-
pational class, cannabisuse in thepastyear, andcommonmen-
tal disorders) to test the hypothesis that psychotic experi-
enceswouldbeassociatedwith impairment ingeneralcognitive
ability (IQ). Because the profile of cognitive impairment in
schizophrenia is characterized by specific deficits in process-
ing speed andmemory in the context of a generalized deficit
andbecausedifferentneural systemsunderlieperformanceon
differentneuropsychological tests, secondary analyses exam-
ined the association between psychotic experiences and in-
dividual neuropsychological test results. We applied a Bon-
ferroni correction to adjust for multiple comparisons in the
secondary analyses, yielding a corrected significance level of
P < .007 (0.05/7).WecomputedCohendeffect sizesusingpos-
testimationmargins (effect sizes of 0.2, 0.5 and0.8 represent
small, medium, and large effects, respectively69).
Toexplore theeffectofageontheassociationbetweenpsy-
chotic experiences and neuropsychological functioning, local
regression curves for age on the interaction of cognition by
group were plotted for each test. To test the effect of age for-
mally, we entered an interaction of group (psychotic experi-
encesvs control) byage (continuous)withcenteredvariables68
into the regressionmodel, adjusting for confounders as above.
Linear regressionanalyseswere subsequently stratifiedbyage
group (16-24, 25-34, 35-49, and ≥50 years), adjusting for con-
founders as above. Age categories were selected based on lo-
cal regression curves and to ensure sufficient power.Owing to
the exploratory nature of the age-stratified analyses, Cohen d
effect sizeswith associated95%CIsonly arepresentedherein.
Confoundingby familial factorswas first examinedbyplot-
ting local regression curves for age on the interaction of cog-
nition by group (controls, participants with psychotic experi-
ences, first-degree relatives, and unrelated cohabitants) for
each test and subsequently using linear regression, as de-
scribed above, across the whole sample to ensure sufficient
power.Weconductedsensitivity analysisusingadifferent cut-
off for the presence of psychotic experiences (ie, yes to ≥1 sec-
ondaryquestionat any level70,71) using linear regression, asde-
scribed above.
Results
Psychotic Experiences
TenparticipantswithmissingPSQdata, 8 participants report-
ing a current or a past diagnosis of psychosis, and 3 partici-
pants currently taking antipsychoticswere excluded from the
analyses. The remaining 1677 participantswere ethnically di-
verse (633 [37.7%]notwhiteBritish),withamean(SD)ageof 40
(17) years (range, 16-90years). Sevenhundred thirty-threepar-
ticipants were male (43.7%).
Based on self-report and medication use, 11 participants
(prevalence, 0.7%) had psychotic illness, which is consistent
with previous reports of prevalence.1,2 The 1-year weighted
prevalence of psychotic experiences, defined as positive re-
sponses to all secondary questions in 1 or more categories on
the PSQ,5 included 171 participants (9.7%), which is consis-
tent with findings from theWorld Health Survey.72
The groupwith psychotic experiences wasmore likely to
be of a minority ethnic background, have a lower occupa-
tional status, have used cannabis in the past year, and have a
common mental disorder (eTable 4 in the Supplement). Age
differences in prevalence were not statistically significant.
Association of Psychotic Experiences
With Neuropsychological Deficits
Table 2 shows the relationship between psychotic experi-
ences and neuropsychological performance before and after
adjusting for confounders. The IQ impairment did not reach
statistical significance when adjusting for confounders
(β = −3.78; t1261 = −1.91; P = .06; Cohen d = −0.22). However,
significant impairments were seen in the WTAR (β = −4.21;
t1347 = −3.02; P = .003; Cohen d = −0.37), SDRT (β = −1.15;
t1385 = −2.84; P = .005; Cohen d = −0.34), VOLT (β = −1.94;
t1455 = −2.59; P = .01; Cohen d = −0.28), and VOLT delay (β
= −0.66; t1411 = −2.37; P = .02; Cohen d = −0.24) scores. Im-
pairments in the WTAR and SDRT scores remained statisti-
cally significant after correcting formultiple comparisons.No
statistically significant impairment in theDSCTscorewas seen
before or after adjusting for confounders.
We performed an exploratory analysis of the association
between each psychotic experience (thought insertion, para-
noia, strange experiences, and hallucinations) and neuropsy-
chological performance.All experienceswere associatedwith
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cognitive impairment, but effect sizes varied (eTable 5 in the
Supplement). The frequency of individual symptoms did not
allow stratification by age.
Association Between Neuropsychological Functioning
and Psychotic Experiences Stratified by Age
Previous studies haveused samples consistingmostly of chil-
drenandadolescentsorofolderadults,but inspectionofTable1
suggests that the association between psychotic experiences
andneuropsychological functioningmaydifferbyage.Figure 1
shows an overall age-associated cognitive decline in both
groups but also a difference in the severity of neuropsycho-
logical impairment associated with psychotic experiences at
different ages. We found significant group-by-age interac-
tions for all neuropsychological measures, including IQ
(P = .006), WTAR (P = .01), SDRT (P = .03), VOLT (P = .001),
VOLT delay (P = .02), and DSCT (P = .01) scores when adjust-
ing for confounders.
After stratifyingby age groupandadjusting for confound-
ers, group differences in mean (SD) IQ (81.22 [15.97] vs 91.28
[14.31]; Cohend = −0.70),WTAR (28.31 [13.83] vs 38.51 [11.50];
Cohen d = −0.88), SDRT (19.11 [4.77] vs 21.99 [3.42]; Cohen
d = −0.82),VOLT(39.17 [8.23]vs44.09[6.51];Cohend = −0.45),
andVOLTdelay (13.09 [2.74] vs 14.34 [2.40]; Cohend = −0.52)
scoresweremediumto large inparticipantswithpsychotic ex-
periences 50 years and older (Figure 2). Medium impair-
ments in SDRT (21.27 [3.64] vs 22.62 [2.97]; Cohen d = −0.45)
andVOLT(44.32 [5.84]vs46.91 [5.74];Cohend = −0.45) scores
were also found in participants aged 35 to 49 years with psy-
chotic experiences and a medium impairment (30.81 [14.17]
vs 37.60 [10.48]; Cohen d = −0.62) and a medium advantage
(44.80 [6.61] vs 38.63 [8.43]; Cohen d = 0.74) inWTAR scores
in thoseaged 16 to24and25 to34years, respectively.All other
impairments in those younger than 50 years were small.
Sensitivity analysis using a different cutoff for the pres-
ence of psychotic experiences70,71 produced similar results
(eFigure 2 in the Supplement). Adjusting additionally for edu-
cational level (eTable 6 and eFigure 3 in the Supplement) also
produced similar results.
Association Between Neuropsychological Functioning
and Psychotic Experiences by Familial Factors
Characteristics of each group are shown in eTable 7 in the
Supplement. Exploratory analyses (eFigure 4 in the Supple-
ment) suggested that WTAR performance was the most and
VOLT performance was the least familial. First-degree rela-
tivesofprobandswere impairedon theWTARscore (β = −3.93;
t1347 = −2.33;P = .02;Cohend = −0.36) after adjusting for con-
founders (Figure3).Nongenetically relatedcohabitantsdidnot
show statistically significant neuropsychological deficits.
Discussion
This study provides evidence that subclinical psychotic expe-
riences are associated with mild neuropsychological impair-
ment in adults. The magnitude of impairment in specific do-
mains suggests impaired verbal and memory functions but
spared processing speed. Only older adultswith psychotic ex-
periences showed medium to large impairments in working
memory and memory when adjusting for sociodemographic
factors, psychiatric morbidity, and cannabis use. First-degree
relatives of probands also had a significant verbal impair-
ment, but not a significantmemory impairment. Our findings
introduce new knowledge and propose new hypotheses re-
gardingtheneuropsychologyofpsychoticexperiences inadults.
Our results are in line with those of the National Survey
of Psychiatric Morbidity in Great Britain,5 which reported a
small verbal IQ deficit in adults reporting psychotic experi-
ences. Although not directly comparable to those from other
previous studies, which have mostly focused on younger or
older samples,19,20,23,24 the adjusted effect sizes we report
Table 2. GroupMeans and Effect Sizes Before and After Adjustments
Cognitive Test
Mean (SD) Score by Group
Effect Size,
Cohen da P Valueb
Effect Size,
Cohen dc P ValuebPsychotic Experiences Control
IQd 95.25 (16.58) 100.45 (14.77) −0.37 <.001 −0.22 .06
WTAR totale 31.36 (15.78) 38.83 (12.64) −0.58 <.001 −0.37 .003
SDRTf
Total 20.97 (4.12) 22.51 (3.26) −0.46 <.001 −0.34 .005
Low load 11.32 (2.40) 12.02 (1.92) −0.36 <.001 −0.27 .02
High load 9.66 (2.13) 10.49 (1.85) −0.45 <.001 −0.33 .004
VOLTg 43.80 (8.45) 46.53 (7.06) −0.38 <.001 −0.28 .01
VOLT delayh 14.27 (2.97) 15.14 (2.75) −0.31 <.001 −0.24 .02
DSCTi 40.63 (13.06) 42.17 (13.79) −0.12 .20 −0.03 .73
Abbreviations: DSCT, digit symbol coding task; SDRT, Spatial Delayed-Response
Task; VOLT, Visual Object Learning Task; WTAR,Wechsler Test of Adult Reading.
a Indicates unadjusted.
bResults are statistically significant at the Bonferroni corrected level of P < .007.
c Indicates adjusted for ethnicity and occupational class, cannabis use in last
year, and commonmental disorders.
d Scores range from 40 to 160, with higher scores indicating better
performance.
e Scores range from0 to 50, with higher scores indicating better performance.
f Scores range from0 to 24, with higher scores indicating better performance.
g Scores range from0 to 60, with higher scores indicating better performance.
h Scores range from0 to 20, with higher scores indicating better performance.
i Scores range from0 to 94, with higher scores indicating better performance.
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closely approximate the pooled effect sizes in our meta-
analytic summary (Table 1). Adjustment for confounders at-
tenuated theprocessing speeddeficit, suggesting that the sig-
nificant processing speed deficits reported in children and
adolescentswithpsychotic experiences19,20maybepartly con-
founded. Alternatively, the cause of processing speed defi-
Figure 1. Local Regression Curves of Neuropsychological Functioning Domains
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Figure 2. Effect Sizes for Each Neuropsychological Domain by Age Group
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cits associated with psychotic experiences may differ be-
tweenadolescenceandadulthood. Indeed, a recent study that
usedadimensionalcategorizationofpsychoticexperiencesalso
did not find differences in processing speed between adults
with low and high levels of psychotic experiences.73
Our findingshighlight similarities, butalsodifferences,be-
tween neuropsychological dysfunction associated with psy-
choticexperiencesvsdisorders.Meta-analyseshaveshownthe
mostseverecognitive impairment inschizophrenia tobe inpro-
cessing speed.44,45 We found only a weak association be-
tweenpsychotic experiences andDSCTperformance. Thedis-
crepancybetweena substantial processing speed impairment
in psychotic disorder and a negligible impairment in psy-
chotic experiences suggests that clinical psychosis is associ-
ated with increasing abnormality in processing speed.74 Our
findingsaddtoagrowingbodyof literature that challengespsy-
chotic experiences as a subclinical phenotype of psychosis.
Identification of factors associated with psychotic experi-
ences that predict transition to psychotic disorder is needed
if they are to be useful in the etiologic investigation of psy-
chosis. Neuropsychological impairment, in processing speed
specifically,maybeone factor. Individualswithpsychotic ex-
periences and processing speed deficits may be most at risk
forpsychosis, and this combinationof risk factorswarrants fur-
ther longitudinal study.
This study was the first, to our knowledge, to investigate
the effect of age on neuropsychological impairment associ-
ated with psychotic experiences in adults. Some studies sug-
gest that theseexperiencesaremostprevalent inadolescence75
and old age,76 whereas meta-analyses have not found signifi-
cant age differences.3,47,48 In our sample, prevalence of psy-
chotic experiences was greatest in the youngest group but re-
mained sizable in the other age groups (eTable 4 in the
Supplement). Only older adults showedmedium to large defi-
cits in IQ, verbal knowledge, working memory, and memory
after adjustment for multiple demographic and psychosocial
factors.Mediumimpairments inworkingmemoryandmemory
were seen in thegroupaged35 to49years and inverbal knowl-
edge in the groupaged 16 to 24years. These findingshighlight
the heterogeneity of extended phenotypic expression associ-
atedwith psychotic experiences throughout adulthood. Etio-
pathologic pathways to subclinical psychotic experiences and
neuropsychological dysfunctionmaybe agedependent (eFig-
ure 5 in the Supplement). In young adults with psychotic ex-
periences,neuropsychological impairmentmaysignala risk for
general psychiatric disorders, possibly owing to psychosocial
stress and/or substance use; however, in older adults, neuro-
psychological impairmentmay indicate vulnerability to accel-
erated cognitive aging. A faster trajectory of cognitive decline
forpatientswithAlzheimerdiseasewithconcurrentdelusions77
and hallucinations78 has been reported. Accelerated shrink-
age of prefrontal and hippocampal regions seen in normal
aging79,80 may lead to disrupted dopamine release and psy-
chotic phenomena81 but also tomore rapid cognitive decline.
By including cohabitants of participants with psychotic
experiences, we explored potential mechanisms behind the
association between psychotic experiences and cognition.
First-degree relatives were significantly impaired on verbal
knowledge, whereas unrelated cohabitants showed no
impairment. Our findings suggest that a complex interplay
of genetic, biological, and psychosocial factors lies behind
the association between psychotic experiences and neuro-
psychological impairment. This pattern of verbal knowledge
impairment suggests common genetic and/or family envi-
ronmental factors. On the other hand, unimpaired memory
functions in both groups of cohabitants support biological
and/or psychosocial effects of psychotic experiences on
memory consistent with a causal effect.
Although we hypothesize that sociodemographic fac-
tors, cannabis use, and common mental disorders are con-
founders, they could also bemediators ormoderators.Media-
tion and confounding are identical statistically but can be
distinguishedconceptually.82Changes associatedwith thehy-
pothalamic-pituitary-adrenal axismay be one area of investi-
gation because the hypothalamic-pituitary-adrenal axis has
been associated with all of these factors and with psychosis
and cognition.83 Shared genetic factors could be another area
of investigation.84,85 Examining interactions between mul-
tiple risk factors is important because complexmultifactorial
traitsare likely toresult fromsuch interactions,andfuturestud-
ies with large samples are required for such investigations.86
Thepresent studyhas anumberof strengths. It is the first,
to our knowledge, to use a large, heterogeneous, representa-
tive sample drawn from an urban community to investigate
the effect of age and familial factors on the association be-
tween psychotic experiences and neuropsychological func-
tioningwhile adjusting for important confounders.Neverthe-
less, several methodologic limitations require consideration.
First, the 51.9%householdparticipation ratewashigh, butwe
were not able to characterize nonresponders on demo-
graphic variables and rule out possible bias owing to nonpar-
ticipation. However, the sample was representative of the lo-
cal populationonmost sociodemographic characteristics.50,71
Figure 3. Effect Sizes for Each Neuropsychological Domain
by Familial Group
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Second, psychotic experiences are fairly common in old age,
presumably owing to neurodegenerative processes,87 andwe
couldnot excludeparticipantswithdementia.However,most
of the participants in the oldest category were aged 50 to 65
years, when dementia is rare,88 andmedium to large impair-
ments in IQ, WTAR, SDRT, and VOLT scores (Cohen d > 0.50
for all) remainedwhenweexcludedparticipants older than65
years. Third, interpretation of effect sizes generally depends
on the assumption of normality, which held true for all tasks
except the WTAR, meaning that effect sizes in verbal knowl-
edge may have been underestimated.
Moreover, those participants with poorer neuropsycho-
logical functioningmayhavebeenmore likely to endorsepsy-
chotic experiences, andyet the associationwasnot present at
all ages or in all domains. We cannot infer from the current
cross-sectional data that psychotic experiences lead to defi-
cits in neuropsychological functioning. Another plausible ex-
planation is that psychotic experiences andneuropsychologi-
cal functioning are manifestations of common underlying
processes.89,90 Finally, the timing andhistory of psychotic ex-
periences cannot be established from the PSQ, meaning that
some psychotic experiencesmay be long-standing. The pres-
ent data provide valuable insight into potential pathways to
adultpsychopathologicdisorders,but future longitudinal stud-
ies that are able to disentangle their temporal sequence and
todeterminewhether these findingsalsoapply to lifetimepsy-
chotic experiences are needed.
Conclusions
The profile of cognitive impairment in adults with psychotic
experiences differed from that found in psychotic disorders.
Our findings highlight the importance of considering age, fa-
milial factors, and the psychosocial context in neuropsycho-
logical studies of psychotic experiences.
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